Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

被引：692

作者：

Sanacora, Gerard ^{[2
]}

Zarate, Carlos A. ^{[1
]}

Krystal, John H. ^{[2
]}

Manji, Husseini K. ^{[1
]}

机构：

[1] NIMH, Mol Pathophysiol Lab, Mood & Anxiety Disorders Res Program, NIH, Bethesda, MD 20892 USA

[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2008年 / 7卷 / 05期

关键词：

D O I：

10.1038/nrd2462

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Mood disorders are common, chronic, recurrent mental illnesses that affect the lives of millions of individuals worldwide. To date, the monoaminergic systems (serotonergic, noradrenergic and dopaminergic) in the brain have received the greatest attention in neurobiological studies of mood disorders, and most therapeutics target these systems. However, there is growing evidence that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in mood-disorder pathophysiology as well as the efficacy of glutamatergic agents in mood disorders. We also discuss exciting new prospects for the development of improved therapeutics for these devastating disorders.

引用

页码：426 / 437

页数：12

共 181 条

[41] Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression [J].

Du, J ;

Gray, NA ;

Falke, CA ;

Chen, WX ;

Yuan, PX ;

Szabo, ST ;

Einat, H ;

Manji, HK .

JOURNAL OF NEUROSCIENCE, 2004, 24 (29) :6578-6589

[42] The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior [J].

Du, Jing ;

Creson, Thomas K. ;

Wu, Long-Jun ;

Ren, Ming ;

Gray, Neil A. ;

Falke, Cynthia ;

Wei, Yanling ;

Wang, Yun ;

Blumenthal, Rayah ;

Machado-Vieira, Rodrigo ;

Yuan, Peixiong ;

Chen, Guang ;

Zhuo, Min ;

Manji, Husseini K. .

JOURNAL OF NEUROSCIENCE, 2008, 28 (01) :68-79

[43] The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders [J].

Du, Jing ;

Suzuki, Katsuji ;

Wei, Yanling ;

Wang, Yun ;

Blumenthal, Rayah ;

Chen, Zheng ;

Falke, Cynthia ;

Zarate, Carlos A., Jr. ;

Manji, Husseini K. .

NEUROPSYCHOPHARMACOLOGY, 2007, 32 (04) :793-802

[44]

DUNAYEVICH E, 2007, NEUROPSYCHOPHAR 0822, DOI DOI 10.1038/SJ.NPP.1301531

[45] The role of dopamine in the pathophysiology of depression [J].

Dunlop, Boadie W. ;

Nemeroff, Charles B. .

ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (03) :327-337

[46] METABOLISM AND ROLE OF GLUTAMATE IN MAMMALIAN BRAIN [J].

ERECINSKA, M ;

SILVER, IA .

PROGRESS IN NEUROBIOLOGY, 1990, 35 (04) :245-296

[47] Functional impairment in the remission phase of bipolar disorder [J].

Fagiolini, A ;

Kupfer, DJ ;

Masalehdan, A ;

Scott, JA ;

Houck, PR ;

Frank, E .

BIPOLAR DISORDERS, 2005, 7 (03) :281-285

[48] N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease [J].

Fan, Mannie M. Y. ;

Raymond, Lynn A. .

PROGRESS IN NEUROBIOLOGY, 2007, 81 (5-6) :272-293

[49] An open-label, flexible-dose study of memantine in major depressive disorder [J].

Ferguson, James M. ;

Shingleton, Richard N. .

CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) :136-144

[50] Glutamatergic systems in Alzheimer's disease [J].

Francis, PT .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 :S15-S21

← 1 2 3 4 5 6 7 8 9 10 →